"Myositis, Inclusion Body" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
|Myositis, Inclusion Body
- Myositis, Inclusion Body
- Inclusion Body Myositides
- Myositides, Inclusion Body
- Inclusion Body Myositis
Inclusion Body Myopathy, Sporadic
- Inclusion Body Myopathy, Sporadic
- Myositis, Inclusion Body, Sporadic
- Myopathy, Inclusion Body, Sporadic
- Inclusion Body Myositis, Sporadic
- Sporadic Inclusion Body Myositis
Below are MeSH descriptors whose meaning is more general than "Myositis, Inclusion Body".
Below are MeSH descriptors whose meaning is more specific than "Myositis, Inclusion Body".
This graph shows the total number of publications written about "Myositis, Inclusion Body" by people in this website by year, and whether "Myositis, Inclusion Body" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Myositis, Inclusion Body" by people in Profiles.
Jackson KL, Lin WL, Miriyala S, Dayton RD, Panchatcharam M, McCarthy KJ, Castanedes-Casey M, Dickson DW, Klein RL. p62 Pathology Model in the Rat Substantia Nigra with Filamentous Inclusions and Progressive Neurodegeneration. PLoS One. 2017; 12(1):e0169291.
Jones KL, Sejersen T, Amato AA, Hilton-Jones D, Schmidt J, Wallace AC, Badrising UA, Rose MR. A protocol to develop clinical guidelines for inclusion-body myositis. Muscle Nerve. 2016 Apr; 53(4):503-7.
Jones K, Pitceathly RD, Rose MR, McGowan S, Hill M, Badrising UA, Hughes T. Interventions for dysphagia in long-term, progressive muscle disease. Cochrane Database Syst Rev. 2016 Feb 09; 2:CD004303.
Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004 May; 14(5):337-45.
Rider LG, Gurley RC, Pandey JP, Garcia de la Torre I, Kalovidouris AE, O'Hanlon TP, Love LA, Hennekam RC, Baumbach LL, Neville HE, Garcia CA, Klingman J, Gibbs M, Weisman MH, Targoff IN, Miller FW. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.